Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes

BACKGROUND: Dry eye disease (DED) is a prevalent complication of diabetes and presents as reduced tear production and/or increased corneal surface sensitivity often with secondary ocular surface changes. This study examined the safety and efficacy of a proprietary new eye drop formulation for topica...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Patricia J., Sassani, Joseph W., Titunick, Michelle B., Zagon, Ian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348650/
https://www.ncbi.nlm.nih.gov/pubmed/30691415
http://dx.doi.org/10.1186/s12886-019-1044-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348650/
https://www.ncbi.nlm.nih.gov/pubmed/30691415
http://dx.doi.org/10.1186/s12886-019-1044-y

Ejemplares similares